placeholder image
A. Jatoi All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • North Central Cancer Treatment Group N0543 (Alliance): a phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma. 
    Cancer. 2017
    • Contact
    full name
  • A. Jatoi
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration